Cabbacis (OTCQB: CABI), a U.S. federally-licensed tobacco product manufacturer and plant biotech company focused on tobacco harm-reduction products, is pleased to announce that its common stock has been approved for listing on the OTCQB. The stock will trade under the symbol CABI. The OTCQB ...
Germany's Merck KGaA in $3.9 billion deal to buy US biotech firm SpringWorks MRK Apr. 28 RE Science in Sport loss narrows in 2024 ahead of takeover by bd-capital SIS Apr. 28 AN Donnet and Sironi at the helm of Generali, which is not discussing the Mediobianca takeover bid ...
The main business of biotech is the development, production and sale of biological vaccines. The main products are varicella vaccine, Purified Hamster Kidney Cell Rabies Vaccine, nasal spray influenza vaccine, and maintain highly independent relationship with other Changchun high and new business sectors...
CURE ETFs S&P Biotech ETF 9,114,810 0 CUV Clinuvel Pharmaceuticals Ltd Health Care 1,148,790,000 0.056 CUX Crossland Strategic Metals Ltd Materials 5,058,230 0 CV1 CV Check Ltd Information Technology 22,791,400 0.001 CVC CVC Ltd Financials 146,697,000 0.007 CVF Contrarian Value Fund Ltd...